Professional Documents
Culture Documents
Tumor Virus Bacteria6473825744
Tumor Virus Bacteria6473825744
Riyani Wikaningrum
Bag. Mikrobiologi
FK Universitas YARSI
1
Malignant transformation
Changes
Details
Morphology
Growth, contact
Cellular properties
Chromosomal changes
Appearance of new antigens (viral or cellular in
origin)
Biochemical properties
Loss of fibronectin
Reduced cAMP
Viruses
Epstein-Barr
virus
Cancer
Strength of
association
Viral genome
in cancer cells
Burkitt's
lymphoma
++
Malaria
Nasopharyngeal
carcinoma
++
Nitrosamine
s
++
? cigarettes
Hodgkin's
disease
Human
papillomavirus
Cervical cancer
Cofactor
? HSV2
Skin cancer
? UV light
Hepatitis B
virus
Liver cancer
++
? Aflatoxin
Hepatitis C
virus
Liver cancer
++
?
Hepatocyte
regeneration
HTLV1
T-cell leukemia
++
HSV2
Cervical cancer
Tumor Viruses
For most viruses:
Replication
Genome
Lysis
Progeny virions
Tumor Viruses
Virus
Cell
Integration (often)
Transformation
Tumor Viruses
Transformation:
Loss of growth control
Reduced adhesion
Motility
Invasion
Ability to form tumors - viral genes interfere with control of
cell replication and other aspects of the cell phenotype
Tumor Viruses
TRANSFORMATION
VIRAL TRANSFORMATION
The changes in the biological functions of a cell that result from
REGULATION
Tumor Viruses
Both DNA and RNA tumor viruses can
transform cells
Integration of viral genome into the host
chromosomes often occurs
Host RNA
polymerase
Viral mRNA
Similar to host cell!
Viral protein
12
IMPORTANT
messenger RNA
viral protein
Virus
13
mRNA
Host enzymes
protein
virus
OR TRANSFORMATION
In transformation usually only EARLY functions are expressed
14
Epidermodysplasia verruciformis
wart
malignant
skin squamous cell carcinoma
16
2008
Dermatology
Online Journal
17
18
Papilloma Viruses
The important transforming genes in
papilloma viruses are: E6 and E7
Early genes - Not encoding structural
proteins
Oncogenes
20
22
v-onc
24
25
Host enzyme
RNA Provirus
Reverse transcriptase
DNA genome
Viral enzyme
28
Long latency
30
Epidemiology:
Strong correlation between
HBV and hepatocellular
carcinoma
China: 500,000 - 1 million new
cases of hepatocellular carcinoma
per year
Taiwan: Relative risk of getting
HCC is 217 x risk of non-carriers
31
virus
DNA genome
Integrase
virus
Integrates
Host RNA polymerase II
RNA genome
host
33
RNA Tumor
Viruses
34
35
37
important
important
HIV
38
Africa, Caribbean
S. America (Peru, Bolivia)
Some Japanese Islands
Okinawa, Kiyushu, Shikoku (12 - 16% infection rate)
39
40
HIV ?
41
Endocytosis
Fusion of membranes
Nucleus
42
RNA/DNA Hybrid
Reverse
transcriptase
Host DNA
polymerase
Integration
Transcription
Host splicing
enzymes
mRNA
43
protein
Genomic RNA
Reverse transcriptase
DNA
RT
primer
Viral
genomicRNA
Reverse
transcriptase
dsDNA
RNA synthesis
initiation site
promotor
RNA pol II
RNA synthesis termination
site
45
Result: New copy of viral RNA is shorter - lacks control sequences
46
Repeat
region
RNA
R
U5
GAG
POL
ENV
U3
DNA
U3
R
LTR
U5
GAG
POL
ENV U3
U5
LTR
47
U5
Viral RNA
U3
R
Reverse
transcriptase
U3
U5
U3
U5
promotor
POLII
POLII
LTR
LTR
POLII
POLII
49
typical retrovirus
U5
GAG
POL
ENV
U3
U5
GAG
POL
ENV
SRC
U3
R
50
U5
GAG
POL
MYB
U3
U5
dGAG
FMS
dENV
U3
U5
dGAG
MYC
dENV
U3
51
Cellular Proto-oncogene
C-onc
52
53
54
U5
GAG
POL
ENV
U3
55
It is close to
C-myc!
Oncogenesis by promotor insertion
57
58
Growth factors
Growth factor receptors
Signal transduction proteins
Transcription factors
59
60
myb
mos
myc
Genes can be
assigned to
sites on
specific
chromosomes
fes: chromosome 15
61
Break in chromosome
14 at q32
myc
Oncogenesis by rearrangement
Tumor
c-onc
Burkitts lymphoma
myc
(8)
new promotor
Ig heavy (8 to 14)
Ig light (8 to 2)
B-cell chronic lymphocytic
bcl-1
leukemia
bcl-2
tcl-1
T cell receptor
leukemia
T cell chronic lymphocytic
leukemia
(14 inversion)
myc
Oncogenes
Mutations in a proto-oncogene are dominant gain
of function mutations
However other oncogenic genes show recessive
mutations
Anti-Oncogenes
Loss of function mutations
Retinoblastoma
p53
64
Proto-oncogenes
Heterozygote
Dominant
mutations
Homozygote
Allele 1
Allele 2
Allele 1
Allele 2
Normal
Mutant
Mutant
Mutant
Binds under
special
circumstances
Mutant
always
binds
Always binds
Mutant
always
binds
Mutant
always
binds
Always binds
65
Function gained
Function gained
Anti-Oncogenes
Recessive mutations
Mutation
Rb Gene
Mutant Rb
growth
Mutant Rb
Mutant Rb
Rb
Rb protein
Heterozygote
Rb
Binds and controls cell cycle
Turns off DNA replication
Homozygote
Function lost
No binding - Growth continues
66
Anti-Oncogenes
Retinoblastoma gene has normal
regulatory function in many cells
Involved in
Retinoblastoma
Lung carcinomas
Breast carcinomas
67
Anti-Oncogenes
P53
Inactivated by
deletion
point mutation
68
E1A region 2
SV 40
Large T
Polyoma
Large T
BK virus
Large T
Lymphotropic virus
Large T
E6, E7
69
Anti-Oncogenes
Retinoblastoma
Adenovirus E1A
Rb Gene
Rb
protein
Rb
105kD
Rb
Rb
Stops replication
70
Anti-Oncogenes
p53
P53 gene
P53 gene
Hepatitis C
P53
P53
P53 gene
Papilloma
P53
Papilloma
proteolysis
P53
DNA
Stops replication
replication
replication
71
72
Helicobacter pylori
Associated with:
Gastric and duodenal cancer
Gastric mucosa-associated lymphoid tissue
(MALT) lymphoma
Inflammatory reaction to H. pylori chronic
atropic gastritis (CAG) metaplasia dysplasia
carcinoma
Other factor (?) genetic or environmental
73